1 of 4

The rise and fall of erythropoiesis-stimulating agents: Medicare reimbursement is the key

Learn more about leaders in oncology through ASCO’s “Luminaries” series

HLA-DRB1*07:01 allele carriage as a predictor of increased risk of lapatinib-induced liver injury

ASCO affiliate health member Peg Ford: A journey from patient to patient advocate